ArticleBlood cancer discovery2023

Global Shift in Alternative Splicing and Therapeutic Susceptibilities in Leukemia Driven by METTL3 Overexpression.

Maxime Janin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.